News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
495,704 Results
Type
Article (9933)
Company Profile (157)
Press Release (485614)
Multimedia
Podcasts (16)
Webinars (7)
Section
Business (171229)
Career Advice (366)
Deals (26334)
Drug Delivery (15)
Drug Development (54215)
Employer Resources (22)
FDA (9926)
Job Trends (8945)
News (243979)
Policy (18347)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (585)
Accelerated approval (21)
ADA (21)
Adcomms (1)
Allergies (98)
Alliances (34401)
ALS (106)
Alzheimer's disease (999)
Antibody-drug conjugate (ADC) (287)
Approvals (10493)
Artificial intelligence (345)
ASCO (166)
Autoimmune disease (206)
Automation (32)
Bankruptcy (269)
Best Places to Work (7135)
BIO (41)
BIOSECURE Act (3)
Biosimilars (122)
Biotechnology (99)
Bladder cancer (135)
Brain cancer (33)
Breast cancer (511)
Cancer (3720)
Cardiovascular disease (221)
Career advice (295)
Career pathing (2)
CAR-T (183)
CDC (2)
Celiac Disease (1)
Cell therapy (515)
Cervical cancer (38)
Clinical research (48708)
Collaboration (1329)
Commercialization (1)
Company closure (3)
Compensation (1403)
Complete response letters (34)
COVID-19 (884)
CRISPR (68)
C-suite (785)
Cystic fibrosis (89)
Data (5651)
Denatured (10)
Depression (109)
Dermatology (60)
Diabetes (350)
Diagnostics (4290)
Digital health (36)
Diversity (2)
Diversity, equity & inclusion (4)
Drug discovery (176)
Drug pricing (16)
Drug shortages (2)
Duchenne muscular dystrophy (178)
Earnings (73690)
Editorial (6)
Employer branding (3)
Employer resources (20)
Events (89060)
Executive appointments (733)
FDA (12491)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (17)
Frontotemporal dementia (23)
Funding (1024)
Gene editing (140)
Generative AI (12)
Gene therapy (350)
GLP-1 (341)
Government (1051)
Grass and pollen (2)
Guidances (284)
Healthcare (9513)
Hematology (95)
HIV (54)
Huntington's disease (24)
IgA nephropathy (62)
Immunology and inflammation (130)
Immuno-oncology (67)
Indications (152)
Infectious disease (1086)
Inflammatory bowel disease (134)
Inflation Reduction Act (8)
Influenza (88)
Intellectual property (255)
Interviews (46)
IPO (12580)
IRA (7)
Job creations (2139)
Job search strategy (281)
JPM (5)
Kidney cancer (19)
Labor market (12)
Layoffs (105)
Leadership (3)
Legal (5279)
Liver cancer (47)
Longevity (18)
Lung cancer (507)
Lymphoma (249)
Machine learning (30)
Management (7)
Manufacturing (551)
Marketing (7)
MASH (120)
Medical device (8721)
Medtech (8844)
Mergers & acquisitions (14761)
Metabolic disorders (737)
mRNA (61)
Multiple sclerosis (106)
NASH (4)
Neurodegenerative disease (233)
Neuropsychiatric disorders (47)
Neuroscience (1881)
NextGen: Class of 2026 (3339)
Non-profit (955)
Now hiring (15)
Obesity (245)
Opinion (30)
Ovarian cancer (159)
Pain (174)
Pancreatic cancer (207)
Parkinson's disease (206)
Partnered (14)
Patents (470)
Patient recruitment (493)
Peanut (32)
People (42753)
Pharmaceutical (31)
Pharmacy benefit managers (8)
Phase 1 (15876)
Phase 2 (21822)
Phase 3 (14699)
Pipeline (6851)
Policy (33)
Postmarket research (1579)
Preclinical (6720)
Press Release (34)
Prostate cancer (189)
Psychedelics (12)
Radiopharmaceuticals (196)
Rare diseases (603)
Real estate (3254)
Recruiting (10)
Regulatory (15056)
Reports (20)
Research institute (680)
Resumes & cover letters (52)
Rett syndrome (39)
RNA editing (8)
RSV (49)
Schizophrenia (107)
Series A (185)
Series B (135)
Service/supplier (4)
Sickle cell disease (64)
Special edition (3)
Spinal muscular atrophy (88)
Sponsored (6)
Startups (2287)
Stomach cancer (5)
Supply chain (51)
Tariffs (2)
The Weekly (6)
Vaccines (354)
Venture capital (36)
Weight loss (92)
Women's health (79)
Worklife (1)
Date
Last 7 days (272)
Last 30 days (1084)
Last 365 days (19784)
2026 (11186)
2025 (20000)
2024 (23633)
2023 (27239)
2022 (35539)
2021 (38229)
2020 (34507)
2019 (24026)
2018 (18175)
2017 (19377)
2016 (18545)
2015 (24829)
2014 (22074)
2013 (18600)
2012 (20697)
2011 (20858)
2010 (20701)
Location
Africa (250)
Alabama (74)
Alaska (2)
Arizona (296)
Arkansas (11)
Asia (18984)
Australia (2282)
California (11837)
Canada (3094)
China (565)
Colorado (471)
Connecticut (398)
Delaware (206)
Europe (27223)
Florida (1730)
Georgia (365)
Hawaii (3)
Idaho (47)
Illinois (703)
India (44)
Indiana (317)
Iowa (13)
Japan (393)
Kansas (108)
Kentucky (31)
Louisiana (26)
Maine (25)
Maryland (1172)
Massachusetts (7788)
Michigan (304)
Minnesota (550)
Mississippi (5)
Missouri (81)
Montana (20)
Nebraska (11)
Nevada (113)
New Hampshire (63)
New Jersey (2584)
New Mexico (12)
New York (2759)
North Carolina (1247)
North Dakota (4)
Northern California (5912)
Ohio (281)
Oklahoma (15)
Oregon (19)
Pennsylvania (2207)
Puerto Rico (21)
Rhode Island (31)
South America (424)
South Carolina (75)
South Dakota (1)
Southern California (4872)
Tennessee (118)
Texas (1901)
United States (38324)
Utah (349)
Vermont (1)
Virginia (153)
Washington D.C. (41)
Washington State (947)
West Virginia (2)
Wisconsin (84)
495,704 Results for "zivo bioscience inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zivo Bioscience, Inc. Announces Transition to OTCID Marketplace
May 13, 2026
·
3 min read
Press Releases
ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO’s Immune-Enhancing Compounds in Poultry
June 23, 2025
·
5 min read
Deals
ZIVO Bioscience Announces Uplisting to OTCQB Market
Zivo Bioscience, Inc. announces it has uplisted the trading of shares of its common stock from the OTC ® Pink Market to the OTCQB ® Venture Market (OTCQB), effective as of the opening of trading on Friday, January 26, 2024.
January 29, 2024
·
4 min read
Press Releases
ZIVO Bioscience to Present at The Microcap Conference 2025
January 23, 2025
·
1 min read
Press Releases
ZIVO Bioscience Reports Progress with Coccidiosis Treatment Licensing Opportunities
December 23, 2024
·
5 min read
BioMidwest
ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study
Zivo Bioscience, Inc. announces additional findings from its 42-day coccidiosis challenge study that demonstrate the product’s positive impact on the cost of broiler production as an alternative to commonly-used antibiotics.
February 7, 2024
·
5 min read
Press Releases
University of Delaware Study Identifies Optimal Formulation of ZIVO’s Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry
May 7, 2025
·
4 min read
Deals
ZIVO Bioscience Announces Reverse Stock Split
Zivo Bioscience, Inc. today announced that the Board of Directors of the Company approved a 1-for-6 reverse stock split (the “Reverse Stock Split”) of its shares of common stock, par value $0.001 (the “Common Stock”) effective at 5:00 p.m. ET on October 26, 2023.
October 26, 2023
·
2 min read
Press Releases
ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry
February 6, 2025
·
4 min read
BioMidwest
ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference
Zivo Bioscience, Inc. announces that management will deliver a company presentation and will hold investor meetings at the 8th Annual Dawson James Small Cap Growth Conference being held Thursday, October 12, 2023.
October 3, 2023
·
3 min read
1 of 49,571
Next
